Click here to view the Providence Health Plan Medical Policy Updates » September 2024 Providence…
BCBS Louisiana Medical Policy Updates – June 2024
Click here to view the Blue Cross Blue Shield BCBS Louisiana Medical Policy Updates »
June 2024 BCBS Louisiana Medical Policy Updates:
- adalimumab (Humira®)
- Adalimumab Biosimilars
- Amniotic Membrane and Amniotic Fluid
- Angiotensin Converting Enzyme-Inhibitors and Angiotensin Converting Enzyme-Inhibitor Combination Drugs
- Auto-injectable/Pre-filled Syringe Methotrexate (Otrexup™, Reditrex™)
- benralizumab (Fasenra™)
- Bioengineered Skin and Soft Tissue Substitutes
- Branded Antivert® Products
- Branded Gabapentin Products
- Cardiac Rehabilitation in the Outpatient Setting
- Chelation Therapy
- Chronic Intermittent Intravenous Insulin Therapy (CIIIT)
- Continuous Passive Motion (CPM)
- Corneal Collagen Cross-linking
- Dermatologic Applications of Photodynamic Therapy
- Dhivy™ (carbidopa/levodopa)
- dichlorphenamide (Keveyis™)
- Electrostimulation and Electromagnetic Therapy for Treating Wounds
- Elivaldogene Autotemcel (Skysona®)
- Enhanced External Counterpulsation (EECP)
- Extended Release Amantadine Products
- Gastric Electrical Stimulation
- Gene Therapy for Inherited Retinal Dystrophy
- Hematopoietic Cell Transplantation for Chronic Myeloid Leukemia
- Hematopoietic Cell Transplantation for Hodgkin Lymphoma
- Hematopoietic Cell Transplantation for Miscellaneous Solid Tumors in Adults
- Hematopoietic Cell Transplantation for Plasma Cell Dyscrasias, Including Multiple Myeloma and POEMS Syndrome
- Hippotherapy
- Intravitreal and Suprachoroidal Corticosteroid Products
- Keratoprosthesis
- Levoketoconazole (Recorlev®)
- L-Glutamine (Endari™)
- Mepolizumab (Nucala®)
- Naxitamab (Danyelza®)
- Nerve Graft With Radical Prostatectomy
- Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
- Ocrelizumab (Ocrevus™)
- Outpatient Pulmonary Rehabilitation
- Iptacopan (Fabhalta )
- Pegcetacoplan (Empaveli™)
- Powered Exoskeleton for Ambulation in Patients With LowerLimb Disabilities
- Reslizumab (Cinqair®)
- Sebelipase Alfa (Kanuma™)
- Surgical Ventricular Restoration
- Tasimelteon (Hetlioz®, Hetlioz LQ™)
- Telotristat (Xermelo™)
- Temporarily Implanted Nitinol Device (iTind) for Benign Prostatic Hyperplasia
- Teprotumumab-trbw (Tepezza™)
- Tetracyclines (oral)
- Tezepelumab-ekko (Tezspire™)
- Transcatheter Arterial Chemoembolization (TACE) to Treat Primary or Metastatic Liver Malignancies
- Ublituximab (Briumvi™)
- Uridine Triacetate (Xuriden™)
- Vagus Nerve Stimulation
- Vestibular Function Testing
- vestronidase alfa-vjbk (Mepsevii™)
- Voclosporin (Lupkynis™)
- Vosoritide (Voxzogo™)
Click here to view the Blue Cross Blue Shield BCBS Louisiana Medical Policy Updates »
How Does Policy Alerts Work?
Policy Alerts’ medical policy monitoring and alerts software continuously monitors Commercial, Medicare, and Medicaid coverage information to keep you up-to-date on coverage changes in real-time.
Policy Alerts’ software locates relevant Payer medical policies and coverage information from across the web. This software monitors that information for updates and changes while also searching for new medical policies and coverage information. Whenever changes occur, Policy Alerts immediately sends out an email notification containing a summary of what has changed.
Clients can access their medical policies and payer coverage summary on the interactive Policy Alerts dashboard. Never miss another important insurance carrier medical policy review or coverage decision update again!
✓ Thousands of subscribers ✓ Easy setup
Related Posts
